Legal Representation
Attorney
Tara Reedy Sliva
USPTO Deadlines 2 active 1 overdue
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
OPPOSITION
Notice of Publication |
NPUBE | May 01, 2025 | 67 days overdue | Medium | Until Jun 01, 2025 |
ITU SOU
Notice of Allowance Mailed - SOU Required |
NOAME | Nov 27, 2025 | 143 days | High | Until May 27, 2026 |
Next deadline: Notice of Allowance Mailed - SOU Required
on November 27, 2025
(143 days)
Application History
15 eventsDate | Code | Type | Description |
---|---|---|---|
May 27, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Apr 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
Apr 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Mar 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 6, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Feb 13, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Feb 13, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 13, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 22, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jan 22, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jan 22, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jan 21, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
Jan 19, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jan 19, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Jun 26, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for scientific and research use in the field of microbiology and molecular biology; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis research purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
Class 005
Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities, for medical treatment purpose and diagnostic use; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties for treating blood disorders, autoimmune diseases, and allergic conditions; Organic chemical preparations and enzymes for medical laboratory diagnostic analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory diagnostic analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); biochemical and organic chemical reagents for clinical diagnostic laboratory use
Active Deadlines
Notice of Publication
Due: May 01, 2025
Overdue
Notice of Allowance Mailed - SOU Required
Due: Nov 27, 2025
Additional Information
Design Mark
The mark consists of the stylized word "STABOLY" with the letter "O" consisting of a circle design with dots inside the circle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005